Helsinn Healthcare S.A.: Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety
Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety Lugano, Switzerland, February 18, 2021 - Helsinn, a Swiss pharmaceutical group focused
Williaml Bailey Larisaj Geskin Paola Bonvicini Helsinn Investment Fund Swiss Pharma Company China Helsinn Pharmaceuticals
Source: finanznachrichten.de